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OOPhotodynamic therapy (PDT) with a recently developed photosensitizer Zn-BC-AM was found to effectively induce apoptosis in a well-differentiated nasopharyngeal carcinoma (NPC) HK-1 cell line. Sustained activation of p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal kinase (JNK) as well as a transient increase in activation of extracellular-regulated kinase (ERK) were observed immediately
after Zn-BC-AM PDT. A commonly used p38MAPK/JNK pharmacological inhibitor PD169316 was found to reduce PDT-induced apoptosis
of HK-1 cells. PD169316 also prevented the loss of Bcl-2 and Bcl-xL in PDT-treated HK-1 cells. However, inhibition of JNK with SP600125
had no effect on Zn-BC-AM PDT-induced apoptosis while inhibition of ERK with PD98059 or p38 MAPK with SB203580 significantly
increased Zn-BC-AM PDT-induced apoptosis. Further study showed that knockdown of the p38b isoform with siRNA also increased Zn-BC-
AM PDT-induced apoptosis, indicating that the anti-apoptotic effect of PD169316 in PDT-treated HK-1 cells was probably independent of
p38MAPKor JNK activation. Taken together, the results suggest that inhibition of p38b and ERKmay enhance the therapeutic efficacy of Zn-
BC-AM PDT on NPC cells. It should be noted that data only based on the use of PD169316 should be interpreted in caution. Copyright#
2010 John Wiley & Sons, Ltd. 93 
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INTRODUCTION
MitogenQ3-activated protein kinases (MAPKs), a group of
protein kinases activated by dual phosphorylation, are
involved in controlling the growth, differentiation, move-
ment and death of cell in response to various stimuli and
stresses.1 There are three major groups of MAPKs produced
by the mammalian cells, namely p38 MAPK, c-jun N-
terminal kinases (JNK) and extracellular signal regulated
kinases (ERKsQ4). ERK is generally involved in the
regulation of proliferation while p38 MAPK and JNK are
frequently activated and participated in stress responses and
programmed cell death.2–4 As deregulation of MAPKs
signalling pathways is known to play a role in neoplastic
transformation and tumour progression, chemotherapeutic
agents targeting on these pathways are currently under*Correspondence to: N. K. Mak, Department of Biology, Hong Kong
Baptist University, 224, Waterloo Road, Hong Kong. Tel: (862) 34117059.
E-mail: nkmak@hkbu.edu.hk
yPresent address: Department of Clinical Oncology, University of Hong
Kong, Hong Kong.
Copyright # 2010 John Wiley & Sons, Ltd.
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 122 development for the treatment of cancer or to improve
response to conventional therapy.
Photodynamic therapy (PDT) is a promising therapeutic
approach for cancer management. In the past decade,
various types of photosensitizers were developed and
evaluated for their efficacy in tumour eradication. It is
now clear that the target of PDT is not restricted to a single
cellular component or a single signalling pathway. Multiple
intracellular components and signalling pathways have been
implicated in PDT-induced cell death.5 The role of MAPKs
in PDT-induced apoptosis has not been fully studied.6,7
Photoactivation of Pc4 was found to induce phosphorylation
of p38 MAPK in CHO cells.8 Similar findings were also
observed in human adenocarcinoma HeLa cells with
hypericin-PDT,9 human keratinocytes HaCat cells and
hypopharyngeal carcinoma FaDu cells treated with ALA-
PDT,10,11 murine keratinocytes Pas 212 cells treated with
benzoporphyrin derivative-PDT12 and also human leukae-
mia HL60 and murine mammary carcinoma 4T1 cells
treated with PORF-TEG-PDT.13 A previous study showed
that Rose Bengal PDT-activated JNK was required for
caspase-3 activation in the A431 carcinoma cells.14 In
contrast, TPPS2a PDT-activated JNK was found to play aReceived 13 February 2009
Revised 16 November 2009
Accepted 4 January 2010
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role in providing survival signals to PDT-treated epithelial
ovarian cancer cells.15 In LFS087 and GM38A cell lines,
ERK was transiently activated by Photofrin PDT,16 whereas
ERK was not affected in another PDT model.12 Therefore,
the action of PDT on the activities of MAPKs was probably
cell line and photosensitizer-dependent.
We have previously demonstrated that Zn-BC-AM PDT
induces apoptosis in NPC cells.17 In the present study, we
aim to study the role of MAPKs in Zn-BC-AM PDT-induced
apoptosis by using specific pharmacological inhibitors and
siRNA for various p38 MAPK isoforms. We found that
knockdown the expression of p38b, but not p38a and p38d
isoform, would enhance Zn-BC-AM PDT-induced apopto-
sis. We also demonstrated the discrepancy in apoptosis
enhancing effect of two commonly used inhibitors
PD169316 and SB203580 in Zn-BC-AM PDT-induced
apoptosis of NPC cells.
MATERIALS AND METHODS
Materials
Inhibitors of p38 MAPK (SB203580), p38 MAPK/JNK
(PD169316), JNK (SP600125) and MEK/ERK (PD98059)
were purchased from Calbiochem. Antibodies against p38a
MAPK, p38bMAPK, p38dMAPK, phospho-p38MAPK (p-
p38) (Thr180/Tyr182), p38 MAPK (p38), phospho-SAPK/
JNK (p-JNK) (Thr183/Tyr185), SAPK/JNK (JNK), phos-
pho-p44/42 MAPK (p-ERK) (Thr202/Tyr204), p44/42
MAPK (ERK), Bcl-xL, Bad, Bax, Bid, caspase-3, -8, -9
and b-actin were purchased from Cell Signalling Technol-
ogy. Bcl-2 antibody was purchased from Dako. Stock
solution of the photosensitizer Zn-BC-AM17 was prepared
in DMSO.
Cell culture
HK-1 cells18 were maintained in RPMI 1640 medium
(GIBCO) supplemented with 10% FBS (GIBCO) and
antibiotics penicillin (50mg/ml)/streptomycin (50mg/ml)
(GIBCO). The cells were maintained and incubated in a
humidified 5% CO2 incubator at 378C.
Zn-BC-AM PDT treatment
Except otherwise stated, HK-1 cells (3 105 cells/dish)
were incubated overnight in 35mm petri dish. Zn-BC-AM
(1mM) was then added and the cells were incubated at 378C
in dark for 24 h. Medium containing Zn-BC-AM was
replaced with fresh medium before light irradiation. The
NPC cells were irradiated at an intensity of 0.8mW/cm2
from a projector equipped with a 400-Watt tungsten lamp, a
heat isolation filter and narrow band filter (682 5 nm).
After light irradiation, the cells were incubated in a 5% CO2
incubator at 378C until further investigation.
PropidiumQ5 iodide exclusion assay
Cell viability was determined by propidium iodide exclusion
assay. Both adherent and floating cells were collected at 24 hCopyright # 2010 John Wiley & Sons, Ltd.ED
 PR
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FS
post-PDT. The cells were then incubated with propidium
iodide (PI, 5mg/ml in PBS) in dark for 5min. The cells were
then immediately analysed by FACSCalibur (Becton
Dickson) with the excitation wavelength at 488 nm.
Fluorescent signals were collected by the FL-2 channel.
Data were further analysed by the CellQuest software.
Clonogenicity assay
Viability of PDT-treated NPC cells was evaluated by the
clonogenicity assay.19 Briefly, the cells were trypsinized and
collected by centrifugation (700g, 5min) after PDT. Various
concentrations of cells were seeded onto 35mm petri dishes
and colony formation was determined 7 days after
incubation. The cell monolayers were then washed twice
with PBS and fixed with absolute methanol for 10min. The
cells were stained with 0.5% of crystal violet for 10min and
rinsed four times with tap water. The stained cells were
allowed to air-dry. The images and the number of colonies in
each dish were captured and analysed with software
Quantity-One (Bio-Rad).
Nucleus staining with Hoechst 33342
HK-1 cells were grown on coverslip placed in 35mm petri
dish and subjected to PDTas described above. At the desired
time point, the cells were stained with 20mg/ml of Hoechst
33342 (Fluka, Allentown) for 30min. Floating cells were
collected and washed twice with PBS and collected
by centrifugation (700g, 5min). Both adherent and floating
cells were pooled and observed under the fluorescence
microscope. The percentage of apoptotic cells was
determined by counting at least 300 cells for each treatment
group.
Western blot analysis
After PDT, total cell lysate was prepared by lysing the cells
with lysis buffer containing 50mM Tris-HCl pH 8.0,
150mMNaCl, 1% NP-40 (USB), 1% phosphatase inhibitors
cocktail (Calbiochem) and 0.25% protease inhibitors cock-
tail (Sigma). Cell debris was removed by centrifuging the
cell lysates at 10 000 g at 48C for 10min. The protein
concentrations were determined using the detergent com-
patible protein assay kit (Bio-Rad). Cellular proteins were
then electrophoretically fractionated by SDS-PAGE. The
separated proteins were electro-blotted to polyvinylidene
difluoride membrane (PVDF, Perkin Elmer) in a transfer
buffer containing 50mM Tris, 150mM glycine, 0.05% SDS
and 20% methanol. The membrane was blocked in 5% non-
fat dry milk in TBST (25mM Tris, 140mM NaCl, 3mM
KCl and 0.1% Tween 20). The membrane was then
incubated sequentially with an appropriately diluted primary
antibody for 2 h and secondary antibody conjugated with
horseradish peroxidase (HRP) for 1 h at room temperature.
Chemiluminescence was detected using the WESTSAVE
UpTM (Abfrontier) and visualized on an X-ray film. QuantityCell Biochem Funct 2010; 28: 1–10.
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One software (Bio-rad) was used to measure the densito-
metry of bands generated from Western blot analysis.
Transfection with plasmid DNA
HK-1 cells (3 105 cells) were seeded in 35mm petri dish
the day before transfection and maintained in complete
medium. 3.75ml of Lipofectamine TM 2000 (Invitrogen) was
added in 200ml serum free medium and then incubated at
room temperature for 5min. 1.6mg of Bcl-2 pcDNA3
plasmid (Addgene plasmid 8768) was added to another
200ml of serum-free medium.20 Transfection complex
(400ml) was then prepared by mixing 200ml plasmid
DNA to 200ml Lipofectamine 2000TM and the mixture was
allowed to incubate for further 30min. During the period of
incubation, the cells were replaced with 1.6ml of fresh
serum-free medium. The transfection complex was trans-
fected to cells and incubated for 6 h. The transfection
complex was then removed, replaced with fresh complete
medium and incubated for overnight. Same amount of
pcDNA3.1 empty vector was used as an internal control and
transfected the cells as described above.
siRNA transfection
HK-1 cells (1.5 105) were seeded in 35mm petri dish the
day before transfection and maintained in complete
medium. To prepare the transfection complex, 3.75ml of
Lipofectamine TM 2000 (Invitrogen) was added to 200ml
serum free medium and the mixture was incubated at room
temperature for 5min. 3.3ml of 20mM siRNAwas added to
another 200ml of serum-free medium. Transfection complex
(400ml) was prepared by adding the siRNA to the
Lipofectamine 2000TM and the mixture was allowed to
incubate for further 30min. Before transfection, the cells
were replaced with 1.6ml of serum-free medium. The
transfection complex was transfected to cells and the
mixture was incubated for 6 h. The transfection mixture was
then removed, replaced with complete medium and then
incubated overnight. Same amount of non-targeting siRNA
was used as an internal control and transfected to the cells as
described above. The antisense sequences of siRNA were:
p38a MAPK (50- GGA AUU CAA UGA UGU GUA UUU-
30, 50- UCU CCG AGG UCU AAA GUAUUU-30, 50- GUA
AUC UAG CUG UGA AUG AUU-30 and 50- GUC CAU
CAU UCA UGC GAA AUU-30), p38b MAPK (50- GCC
CUG AGG UUC UGG CAA AUU-30, 50- CGA CGA GCA
CGU UCA AUU CUU-30, 50- CCA UAG ACC UCC UUG
GAA GUU-30 and 50- GCG CCG ACC UGA ACA ACA
UUU-30), p38d MAPK (50- GCU CAA AGG CCU UAA
GUA CUU-30, 50- GGA GUG GCAUGA AGC UGU AUU-
30, 50- GGA UUU CAC UCA GCU GUU CUU-30 and 50-
GCC GUU UGA UGA UUC CUU AUU-30) and non-
targeting pool (50- UGG UUU ACA UGU CGA CUA A-30,
50- UGG UUU ACA UGU UGU GUG A-30, 50- UGG UUU
ACA UGU UUU CUG A-30 and 50- UGG UUU ACA UGU
UUU CCU A-30).Copyright # 2010 John Wiley & Sons, Ltd.ED
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Statistical analysis
All graphs were plotted and analysed by the software
Microsoft Excel, SigmaPlot and SPSS. Statistical
significance (p< 0.05) was determined using Student’s
t-test.
RESULTS
Zn-BC-AM PDT-induced cell death and apoptosis in
HK-1 cells
The viability of Zn-BC-AM PDT-treated HK-1 cells was
firstly evaluated by the assessment of the integrity of cell
membrane and the ability of the treated cells for colony
formation. The results showed that the percentage of PI
stained cells was increased in a drug and light-dose
dependent manner (Figure 1A). At the concentration of
1mM, Zn-BC-AM PDT also effectively reduced the colony
formation in a light dose-dependent manner, indicating that
Zn-BC-AM PDT-treated HK-1 cells underwent irreversible
cell damage (Figure 1B). To determine whether Zn-BC-AM
PDT induced apoptotic cell death in HK-1 cells, the
morphological changes and the downstream apoptotic
biomarkers were examined. Cell shrinkage and plasma
membrane blebbing were observed in cells at 2 and 4 h post-
PDT. Chromatin condensation (Figure 1C), one of the
features of apoptotic nuclei, was also observed. In addition,
proteolytic cleaved fragments of the apoptotic initiator
caspase-9 (MW: 37 and 35) and apoptotic executioner
caspase-3 (MW: 19 and 17) were detected at 0.5–8 h post-
PDT. The appearance of the cleaved fragments of caspase-8
(MW: 43 and 41) was also observed at 2 h post-PDT
(Figure 1D).Involvement of Bcl-2 family proteins in Zn-BC-AM
PDT-induced apoptosis
We further characterized the expression levels of anti-
apoptotic (Bcl-2, Bcl-xL) and pro-apoptotic Bcl-2 family
proteins (Bad, Bid and Bax) in Zn-BC-AM PDT-treated HK-
1 cells. Results from the Western Blot analysis (Figure 2A)
of whole-cell lysates revealed an immediate reduction (i.e.
post-PDT, 0 hr) of Bcl-2, Bcl-xL and Bad after Zn-BC-AM
PDT. The level of Bid started to decrease at 4 h post-PDT.
However, the activated form of Bid (truncated Bid, tBid) was
not detected in the PDT-treated cells. In contrast, the protein
level of Bax remained unchanged between 0 and 8 h post-
PDT. To further establish the role of Bcl-2 in HK-1 cells,
Bcl-2 was overexpressed before PDT. Overexpression of
Bcl-2 resulted in a significant reduction of apoptosis in HK-1
cells (Figure 2B). The percentage of apoptotic cells was
reduced from 60 to 40% (p< 0.05). Overexpression of Bcl-2
also reduced the expression level of cleaved caspase-3 in
PDT-treated HK-1 cells (Figure 2C). This observation
clearly indicated that overexpression of Bcl-2 would reduce
PDT-induced apoptosis of HK-1 cells.Cell Biochem Funct 2010; 28: 1–10.
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Figure 1. Zn-BC-AM PDT-induced apoptosis in HK-1 cells. HK-1 cells were incubated with Zn-BC-AM (0.5–1mM) for 24 h, followed by light irradiation at
various light doses (0.25–1 J/cm2) as described in Materials and Methods. (A) Cell viability was determined at 24 h post-PDT by PI exclusion assay. Data were
analysed by the CellQuest software and the results were expressed as meanSD (n¼ 3) (B) Determination of the colony formation 7 days post-PDT. The cell
monolayers were fixed and stained as described in Materials andMethods. The number of colonies in each group was analysed using the software Quantity-One
(Bio-Rad) and the results were expressed as the mean SD (n¼ 3). (C) Staining of apoptotic nuclei by Hoechst 33342. White arrows indicated the membrane
blebbing (in DIC images), chromatin condensation and apoptotic nuclei. (D) Kinetics of expression of cleaved caspase-8, -9 and -3 in PDT-treated HK-1 cells.
Cell, untreated HK-1 cells; Drug, Zn-BC-AM alone.
4 h. k. koon ET AL.
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To determine whether Zn-BC-AM PDT activated the
phosphorylation of MAPKs, the states of phosphorylation
of p38 MAPK, JNK and ERK were analysed (Figure 3). A
very low background level of p-p38 was detected in the
untreated HK-1 and Zn-BC-AM-treated HK-1 cells. An
apparent increase in p-p38 was observed immediately after
Zn-BC-AM PDT. The time course of increase in p-JNK was
similar to p-p38. In contrast, constitutive expression of p-
ERK was observed in the untreated HK-1 cells. A transient
increase followed by a decrease of the p-ERK was observed
after Zn-BC-AM PDT. The p-ERK signal was restored to the
control level at 4 h post-PDT. The restoration of p-ERK
expression might be derived from the surviving cells.
PD169316 reduced Zn-BC-AM PDT-induced apoptosis
PD169316 is a general use p38MAPK/JNK dual inhibitor.
The effect of increasing concentrations of PD169316 on theCopyright # 2010 John Wiley & Sons, Ltd.phosphorylation of p38 MAPK and JNK induced by Zn-BC-
AM PDTwas firstly examined. A dose dependent inhibition
of phosphorylation of p38 MAPK and JNK by PD169316
was observed in PDT-treated HK-1 cells (Figure 4A). At the
concentrations of 1–2.5mM, PD169316 was found to have a
greater inhibitory effect on the production of p-p38 MAPK
than p-JNK. A higher concentration of PD169316 (5–
10mM) was needed to inhibit the phosphorlyation of JNK
induced by Zn-BC-AM PDT. Under the same experimental
condition, PD169316 (1–10mM) also dose dependently
reduced the percentage of apoptotic cells in PDT-treated
HK-1 cells (Figure 4B). The anti-apoptotic effect of
PD169316, as judged from the reduction of the cleaved
caspase-9, -8 and -3, was also observed (Figure 4C).
Previous studies have shown that MAPK phosphorylation
may impair the anti-apoptotic function of Bcl-2 family
proteins and result in apoptotis. As PD169316 was found to
inhibit phosphorylation of p38 MAPK and JNK, we further
examined the effect of PD169316 on the expression of anti-
apoptotic Bcl-2 proteins (Figure 4D). PDT significantly
reduced the expression level of Bcl-2 (Figure 4E) and Bcl-Cell Biochem Funct 2010; 28: 1–10.
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Figure 2. Expression of Bcl-2 family member proteins in Zn-BC-AM
PDT-treated HK-1 cells. HK-1 cells were incubated with Zn-BC-AM
(1mM) for 24 h. The cells were then irradiated with a light dose of 1 J/
cm2 as described in Materials and Methods. (A) Kinetics of Bcl-2 family
protein expressions after PDT. (B) Effect of Bcl-2 overexpression on the
proteolytic cleavage of caspase-3 after PDT. Cell lysates were prepared at
4 h post-PDT. (C) Bcl-2 overexpression reduced PDT-induced apoptosis of
HK-1 cells. The percentage of apoptotic cells was counted at 4 h post-PDT.
At least 400 cells were counted for each group. Results were expressed as
the meanSD (n¼ 3).  p< 0.05 versus PDT in HK-1-pcDNA 3.1.
Figure 3. Kinetics of MAPKs activation induced by Zn-BC-AM PDT.
HK-1 cells were incubated with Zn-BC-AM (1mM) for 24 h, followed by
irradiation with light dose of 1 J/cm2 as described in Materials andMethods.
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 122 xL (Figure 4F) in HK-1 cells. In the presence of PD169316,
the expression level of Bcl-2 and Bcl-xL was restored. Taken
together, these observations suggested that PD169316 may
reduce PDT-induced apoptosis via the early inhibition of
phosphorylation of p38 MAPK and JNK, reduction of PDT-Copyright # 2010 John Wiley & Sons, Ltd.ED
 PR
Oinduced photodamage of anti-apoptotic Bcl-2 proteins and
the subsequent proteolytic cleavage and activation of
downstream effector caspases.
Contribution of p38 MAPK and JNK to Zn-BC-AM
PDT-induced apoptosis in HK-1 cells
Since Zn-BC-AM PDT was found to induce the phos-
phorylation activation of p38 MAPK, JNK and ERK in HK-
1 cells, specific kinase pharmacological inhibitors were used
to evaluate the effect of p38 MAPK, JNK and ERK
inhibition on the formation of apoptotic cells after Zn-BC-
AM PDT.We pre-treated the HK-1 cells with different doses
of PD169316 (10–40mM), SB203580 (10–40mM, a
preferential p38 MAPK inhibitor) or SP600125 (5–
20mM, a preferential JNK inhibitor), for 1 h before light
exposure (1–2 J/cm2). The inhibitor was retained in the
medium until sample harvesting. Apoptosis was then
enumerated at 4 h post-PDT (Figure 5). The percentage of
apoptotic cells in the control and various MAPK inhibitors-
treated HK-1 cells was less than 4%. PD169316 (10 mM)
was found to reduce the percentage of apoptosis at the light
dose of 1–2 J/cm2 (Figure 5A) and the inhibition was in a
drug dose-dependent manner (Figure 5B). As PD169316 is a
dual p38MAPK/JNK inhibitor, it is logically to deduce that
SB203580 and SP600125 may also reduce PDT-induced
apoptosis of HK-1 cells to a certain extent. However,
SB203580 (10mM) was found to enhance the percentage of
apoptosis of PDT-treated HK-1 cells (Figure 5C and 5D).
Furthermore, apoptosis was not affected by the JNK
inhibitor SP600125 (Figure 5E and 5F).
To further confirm the actions of PD169316, SB203580
and SP600125, we checked for the state of phosphorylation
of p38 MAPK and JNK in PDT-treated HK-1 cells. As
shown in Figure 5G, an increased in the expression level of
p-p38 p-JNK was observed at 10min post-PDT. The
expression of both p-p38 and p-JNK could be reduced by
PD169316. The phosphorylation of their downstream targetCell Biochem Funct 2010; 28: 1–10.
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Figure 4. Reduction of Zn-BC-AM PDT-induced apoptosis by PD169316. HK-1 cells (3 105) in 35mm petri dish were treated with Zn-BC-AM (1mM) as
described in Materials and Methods. Before light irradiation (1 J/cm2), the cells were treated with various concentrations of PD169316. (A) Dose dependent
inhibition of production of p-p38 and p-JNK at 10min post-PDT. (B) Reduction of proteolytic cleavage of caspase-8, -9 and -3 by PD169316. (C) Reduction of
PDT-induced formation of apoptotic cells. At least 400 cells were counted for each group. The percentage of apoptotic cells was expressed as the meanSD
(n¼ 3).  p< 0.05 versus PDT alone. (D) Western blotting analysis of Bcl-2 and Bcl-xL expression. Cell lysates were prepared at 0–2 h post-PDT. (E) and (F)
Statistical analysis on the ratios between Bcl-2 or Bcl-xL and b-actin in cells with or without PD169316 treatment. # p< 0.05 versus untreated cell control; 
p< 0.05 versus PDT.
6 h. k. koon ET AL.
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COATF-2 was also reduced. Similarly, the expression of p-p38(Figure 5H) and p-JNK (Figure 5I) was reduced by their
respective inhibitor SB203580 and SP600125 in HK-1 cells.
Transient knockdown of p38b isoform enhanced
Zn-BC-AM PDT-induced apoptosis
Since PD169316 and SB203580 exerted an opposing effect
on PDT-induced apoptosis of HK-1 cells, we applied the
siRNA knockdown technology to dissect the role of p38
MAPK on Zn-BC-AM PDT-induced apoptosis. Four p38
MAPK isoforms were previously identified in mammalian
cells, namely p38a,21 p38b,22 p38d ,23 and p38g .24 Since the
expression of p38g is restricted in skeletal muscle, heart,
thymus and testis,25,26 the role of p38a, p38b and p38d in
Zn-BC-AM PDT-induced apoptosis of HK-1 cells was
examined using siRNA specifically for the expression ofCopyright # 2010 John Wiley & Sons, Ltd.these three p38 MAPK isoforms. In the control experiment,
siRNA specifically reduced the expression of their
corresponding target (Figure 6A). The formation of
apoptotic cells was then determined (Figure 6B). Only
HK-1 cells transfected with siRNA of p38b enhanced the
percentage of apoptotic cells (83.1%, p< 0.05) after PDT
(Figure 6C). Knockdown of either p38a or p38d had no
significant effect on the formation of apoptotic cells induced
by Zn-BC-AM PDT. The result from this study is consistent
with the enhancement of apoptosis by SB203580 in PDT-
treated HK-1 cells (Figure 5C and 5D).
Effects of PD98059 on Zn-BC-AM PDT-induced ERK
phosphorylation and apoptosis
In addition to p38 MAPK and JNK, the expression of
phosphorylated ERK (p-ERK) was also increased after Zn-Cell Biochem Funct 2010; 28: 1–10.
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Figure 5. Effect of PD169316, SB203580 and SP600125 on Zn-BC-AM PDT-induced apoptosis. Zn-BC-AM-loaded HK-1 cells were pre-treated with 10mM
PD169316 (A), 10mMSB203580 (C) or 5mMSP600125 (E) for 1 h before light irradiation (1 and 2 J/cm2). Effect of various doses of PD169316 (B), SB203580
(D) and SP600125 (F) on the production of apoptotic cells. Cells were irradiated at 1 J/cm2. Percentage of apoptotic cells were expressed as meanSD (n¼ 3).
p< 0.05 versus PDT control. Effect of various inhibitors on the expression p-p38, p-JNK and their downstream target ATF-2 at 10min post-PDT (1 J/cm2) (G,
H and I). The concentrations of inhibitors used in this study were the same as A, C and E.
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 122 BC-AM PDT (Figure 3). The effect of MEK/ERK inhibitor
PD98059 on Zn-BC-AM PDT-induced apoptosis was then
examined. The expression of p-ERK in PDT-treated HK-1
cells was significantly reduced by PD98059 (Figure 7A).Copyright # 2010 John Wiley & Sons, Ltd.The basal expression level of p-ERK was also reduced by
PD98059. In the functional study, PD98059 dose depen-
dently enhanced PDT-induced apoptosis of HK-1 cells
(Figure 7B).Cell Biochem Funct 2010; 28: 1–10.
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Figure 6. Effect of knockdown of the p38a, p38b and p38d isoforms on the formation of apoptotic cells induced by Zn-BC-AM PDT. HK-1 cells (1.5 105)
were grown overnight and then transiently transfected with siRNA-transfecting reagent complexes as described in Materials and Methods. (A) Specificity of
siRNA p38MAPK isoforms. Expression of the corresponding p38MAPK isoforms was determined byWestern Blot. (B) Transfected cells were incubated with
or without Zn-BC-AM (1mM) for 24 h. Mediumwas replaced with fresh medium before light irradiation. The cells were stained with Hoechst 33342 for 30min
before harvesting. Fluorescence images were captured under a fluorescence microscope at 4 h post-PDT. (C) Percentage of apoptotic cells. At least 300 cells for
each treatment were counted. Results were expressed as the meanSD (n¼ 3). p< 0.05 versus PDT siRNA control.
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These include the cell growth and proliferation, differen-
tiation, cell movement and cell death in response to various
stimuli and stresses.1 ERK pathway is generally activated by
mitogens and growth factors while p38 MAPK and JNK
pathways are activated in response to chemical stimuli and
environmental stresses. In addition, activation of MAPKs by
different stresses such as UV27–31 and heat32 also leads to
apoptosis. Hence, MAPKs play an important role in the
apoptotic signalling pathways. Many chemotherapeutic
agents are known to induce tumour cell death via the
modulation of the MAPKs signalling pathways. For
example, microtubule inhibitors (vinca alkaloids and
paclitaxel) induce a sustained activation of JNK in many
tumour cells.33–35 Cisplatin, a DNA-damaging chemother-
apeutic drug, activates p38 MAPK in ovarian carcinoma
cells before the onset of apoptosis.36 Hence, the response of
the MAPK signalling pathways to PDT is complex.37
Therapeutic effect of PDT basically relies on the
generation of reactive oxygen species by the photoactivated
photosensitizers. Since MAPKs are sensitive to oxidative
stress, we hypothesize that MAPKs are also involved in Zn-
BC-AM PDT-induced apoptosis of NPC cells. We have
previously demonstrated that PDT induces apoptosis inCopyright # 2010 John Wiley & Sons, Ltd.undifferentiated NPC cells.38–41 In the present study, we
further demonstrated the role of MAPKs in Zn-BC-AM
PDT-induced apoptosis of the well-differentiated NPC cells.
Zn-BC-AM PDT was found to enhance phosphorylation
activation of all three major MAPKs, namely p38 MAPK,
JNK and ERK, immediately after PDT. Using two different
approaches, namely pharmacological inhibition with p38
MAPK inhibitor SB203580 and knockdown the expression
of p38b with siRNA, we found that inhibition of phosphoryl-
ation of p38b would enhance Zn-BC-AM PDT-induced
apoptosis of HK-1 cells. Differential role of p38 MAPK
isoforms has previously been reported in certain studies of
apoptotic cell death. Translational knockdown of p38a was
found to diminish the death receptor-mediated cleavage of
caspase-3 in Jurkat cells. In contrast, knockdown of p38b
sensitized the cells to apoptosis in the same cell model.42 On
the other hand, inhibition of p38awould prevent the death of
cardiomyocytes caused by a combination of prolonged
hypoxia followed by reoxygenation, while p38b exerted a
protective role in response to the hypoxic stress.43 Although
p38d is preferentially expressed in keratinocytes25 and p38d
is also detected in HK-1 cell, knockdown of p38d shows no
significant effect on PDT-induced apoptosis of HK-1 cells.
These observations suggested that the p38b may be a
potential therapeutic target to enhance the efficacy of PDT-
induced apoptosis of NPC cells.Cell Biochem Funct 2010; 28: 1–10.
T
Figure 7. Effect of PD98059 on PDT-induced apoptosis. HK-1 cells
(3 105) in 35mm petri dish were grown overnight and then incubated
with Zn-BC-AM (1mM) for 24 hours. The cells were then treated with
MEK/ERK inhibitor PD98059 (40mM) for 1 h before light irradiation. (A)
Effect of PD98059 on the expression of phosphorylated ERK in PDT-treated
HK-1 cells. Cell lysates were collected at 10min post-PDT (1 J/cm2). (B)
Dose dependent augmentation of PDT-induced production of apoptotic cells
by PD98059. Apoptotic cell count was performed at 4 h post-PDT. Results
were expressed as meanSD (n¼ 3). p< 0.05 versus PDT control.
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inhibitor.44–46 In the present study, although PD169316 and
SB203580 inhibit the phosphorylation of p38MAPK and the
downstream target ATF-2, these two inhibitors exert an
opposing effect in PDT-treated HK-1 cells. The discrepancy
in the action between PD169316 (anti-apoptotic) and
SB203580 (apoptosis enhancing) in PDT-treated HK-1 cells
is unknown. Specificity of chemical inhibitors is always a
concern especially in the cellular system when the inhibitors
were used at the range of micromolar concentrations. p38
MAPK inhibitors had previously been shown to inhibit many
enzymes outside of the MAPK family.47 The anti-apoptotic
effect of PD169316 might be due to the off-target effect of
the inhibitors in the HK-1 cells. The possible action of
PD169316 in PDT-treated NPC cells is currently under
investigation.
Apart from p38b, the ERK inhibitor PD98059 also
enhanced the production of apoptotic cells after Zn-BC-AM
PDT. ERK is generally considered as a survival kinase
involved in the control of cell growth. Unlike p38 MAPKs
and JNK, p-ERK is constitutively expressed in the HK-1
cells. It is interesting to note that PD98059 also inhibits the
basal expression level of p-ERK in the control HK-1 cells.
However, the viability of the cell was not affected. This mayCopyright # 2010 John Wiley & Sons, Ltd.ED
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be explained by the fact that other signalling pathways such
as PI3K/AKT and NF-kB are also involved in the regulation
of cell survival. In the PDT-treated HK-1 cells, p-ERK
appears to counteract PDT-induced apoptosis as inhibition
of the expression of p-ERK results in augmentation of PDT-
induced apoptosis of HK-1. This explanation is supported by
the previous observation that sustained activation of ERK1/2
would protect cells from PDT-induced damage.16
Combination of p38 MAPK inhibitor and PDT in clinical
application is worthy for discussion. First of all, inhibition of
specific p38 isoform can directly enhance apoptosis of PDT-
treated tumour cells. Secondly, p38 MAPK inhibition may
indirectly control the growth of tumour cells. A recent study
showed that p38 MAPK inhibitor would suppress PDT-
induced VEGF production.48 VEGF is one of the key
angiogenic factors and anti-angiogenesis is a strategy
currently used in cancer therapy. Combination of PDT
and selective p38 MAPK inhibition might enhance the
efficacy of the treatment. However, this treatment approach
needs to further be tested in the animal model.
In summary, we demonstrated that Zn-BC-AM PDT-
induced apoptosis in the well differentiated HK-1 NPC cells
could be enhanced by the inhibition of p38b isoform and
ERK. The protective effect of PD169316 in Zn-BC-AM
PDT-induced apoptosis of the HK-1 cells is likely beyond
the action on p38 MAPK and JNK. The use of PD169316 as
the p38MAPK/JNK inhibitor for the investigation of the
apoptotic cell death should be in caution. Other methods
such as siRNA are recommended to be used in parallel to the
chemical inhibitors.
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